Biostem Technologies IncOTC Pink - Current Information:BSEM
- LAST PRICE13.4900
- TODAY'S CHANGE (%)1.4540 (12.0804%)
- Bid / Lots12.1100/ 1
- Ask / Lots14.8700/ 1
- Open / Previous Close11.9900 / 12.0360
- Day Range
- 52 Week Range
- Volume112,393
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BSEM |
|---|---|---|
| 09:32 ET | 3285 | 11.9975 |
| 09:33 ET | 5900 | 12.03 |
| 09:35 ET | 100 | 12.0875 |
| 09:37 ET | 700 | 12.24 |
| 09:42 ET | 400 | 12.5 |
| 09:44 ET | 350 | 12.91 |
| 09:48 ET | 100 | 13 |
| 09:50 ET | 400 | 13.1 |
| 09:51 ET | 605 | 13.3125 |
| 09:53 ET | 350 | 13.52 |
| 09:55 ET | 2800 | 13.6 |
| 09:57 ET | 3990 | 13.0001 |
| 10:02 ET | 2750 | 13.6 |
| 10:04 ET | 2004 | 13.34 |
| 10:06 ET | 200 | 13.321 |
| 10:08 ET | 2688 | 13.2585 |
| 10:11 ET | 1200 | 13.47 |
| 10:13 ET | 3298 | 13.35 |
| 10:15 ET | 501 | 13.39 |
| 10:18 ET | 1490 | 13.26 |
| 10:20 ET | 300 | 13.26 |
| 10:22 ET | 3100 | 13.3 |
| 10:26 ET | 2100 | 12.87 |
| 10:29 ET | 100 | 12.9315 |
| 10:33 ET | 500 | 12.99 |
| 10:38 ET | 2000 | 13.295 |
| 10:40 ET | 600 | 13.3 |
| 10:44 ET | 750 | 13.01 |
| 10:49 ET | 10205 | 13.11 |
| 10:54 ET | 400 | 13.15 |
| 10:58 ET | 1832 | 13.24 |
| 11:02 ET | 1955 | 13.2755 |
| 11:03 ET | 1763 | 13.3 |
| 11:07 ET | 900 | 13.25 |
| 11:36 ET | 100 | 13.34 |
| 11:43 ET | 100 | 13.3 |
| 11:54 ET | 167 | 13.1765 |
| 12:01 ET | 2872 | 13.35 |
| 12:03 ET | 10765 | 13.49 |
| 12:06 ET | 700 | 13.48 |
| 12:08 ET | 800 | 13.427 |
| 12:14 ET | 1100 | 13.427 |
| 12:19 ET | 2426 | 13.373 |
| 12:24 ET | 1100 | 13.49 |
| 12:30 ET | 400 | 13.454 |
| 12:32 ET | 100 | 13.49 |
| 12:33 ET | 823 | 13.49 |
| 12:35 ET | 900 | 13.427 |
| 12:48 ET | 100 | 13.418 |
| 12:51 ET | 1000 | 13.49 |
| 12:53 ET | 10000 | 13.5 |
| 12:57 ET | 200 | 13.7 |
| 01:00 ET | 500 | 13.7 |
| 01:06 ET | 2300 | 13.51 |
| 01:08 ET | 200 | 13.4 |
| 01:09 ET | 300 | 13.4 |
| 01:22 ET | 490 | 13.4 |
| 01:51 ET | 250 | 13.6 |
| 02:12 ET | 950 | 13.58 |
| 02:27 ET | 1450 | 13.259 |
| 02:30 ET | 1200 | 13.345 |
| 02:32 ET | 300 | 13.365 |
| 02:36 ET | 375 | 13.3535 |
| 02:38 ET | 700 | 13.365 |
| 02:39 ET | 500 | 13.3535 |
| 02:41 ET | 166 | 13.48 |
| 02:43 ET | 1245 | 13.4 |
| 03:01 ET | 1482 | 13.485 |
| 03:08 ET | 350 | 13.485 |
| 03:14 ET | 300 | 13.48 |
| 03:19 ET | 850 | 13.391 |
| 03:48 ET | 100 | 13.49 |
| 03:55 ET | 1164 | 13.445 |
| 04:00 ET | 100 | 13.49 |
Yesterday
Press Release: BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global, from 7:03AM ET on Wednesday Nov 20, 2024 by Dow Jones
7:03AM ET on Wednesday Nov 20, 2024 by Dow JonesBioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global, from 7:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 12, 2024
BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million, from 7:29AM ET on Tuesday Nov 12, 2024 by Dow Jones
7:29AM ET on Tuesday Nov 12, 2024 by Dow Jones
Oct 29, 2024
Oct 28, 2024
BioStem Technologies to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024, from 1:58PM ET on Monday Oct 28, 2024 by Dow Jones
1:58PM ET on Monday Oct 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biostem Technologies Inc | 196.0M | 21.4x | --- |
scPharmaceuticals Inc | 168.1M | -1.8x | --- |
Precigen Inc | 238.9M | -1.6x | --- |
Telomir Pharmaceuticals Inc | 124.4M | -5.5x | --- |
ImmuCell Corp | 32.1M | -7.5x | --- |
Dr Reddy's Laboratories Ltd | 12.0B | 18.5x | +24.18% |
Company Information
BioStem Technologies, Inc. is focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts and regenerative therapies. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. Its products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AmnioWrap2. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. AmnioWrap is a placental-based allografts comprised of unseparated amnion and chorion membranes, including the intact intermediate layer.
Contact Information
- Headquarters
- 2836 Center Port CirPOMPANO BEACH, FL, United States 33064-2136
- Phone
- 954-380-8342
- Fax
- ---
Executives
- Chairman of the Board
- Thomas Dugan
- President, Chief Executive Officer, Director
- Marc Barhonovich
- Chief Financial Officer, Secretary, Treasurer, Director
- Leon Willis
- Chief Commercial Officer
- Shawn Mccarrey
- Chief Medical Officer
- Dave Woynarowski
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $196.0M |
|---|---|
Revenue (TTM) | $210.4M |
Shares Outstanding | 16.3M |
Biostem Technologies Inc does not pay a dividend. | |
Beta | 1.46 |
EPS | $0.63 |
Book Value | $-0.06 |
P/E Ratio | 21.4x |
Price/Sales (TTM) | 0.9 |
Price/Cash Flow (TTM) | 13.5x |
Operating Margin | 9.75% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
